Literature DB >> 24276464

Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size.

Xiao Yin1, Ian R Lanza, James M Swain, Michael G Sarr, K Sreekumaran Nair, Michael D Jensen.   

Abstract

CONTEXT: It has been suggested that mitochondrial dysfunction in adipocytes contributes to obesity-related metabolic complications. However, obesity results in adipocyte hypertrophy, and large and small adipocytes from the same depot have different characteristics, raising the possibility that obesity-related mitochondrial defects are an inherent function of large adipocytes.
OBJECTIVE: Our goal was to examine whether obesity, independent of fat cell size and fat depot, is associated with mitochondria dysfunction.
DESIGN: We compared adipocyte mitochondrial function using a cross-sectional comparison study design.
SETTING: The studies were performed at Mayo Clinic, an academic medical center. PATIENTS OR OTHER PARTICIPANTS: Omental and/or abdominal subcutaneous adipose samples were collected from 20 age-matched obese and nonobese nondiabetic men and women undergoing either elective abdominal surgery or research needle biopsy. INTERVENTION: Interventions were not conducted as part of these studies. MAIN OUTCOME MEASURES: We measured mitochondrial DNA abundance, oxygen consumption rates, and citrate synthase activity from populations of large and small adipocytes (separated with differential floatation).
RESULTS: For both omental and subcutaneous adipocytes, at the cell and organelle level, oxygen consumption rates and citrate synthase activity were significantly reduced in cells from obese compared with nonobese volunteers, even when matched for cell size by comparing large adipocytes from nonobese and small adipocytes from obese. Adipocyte mitochondrial content was not significantly different between obese and nonobese volunteers. Mitochondrial function and content parameters were not different between small and large cells, omental, and subcutaneous adipocytes from the same person.
CONCLUSION: Adipocyte mitochondrial oxidative capacity is reduced in obese compared with nonobese adults and this difference is not due to cell size differences. Adipocyte mitochondrial dysfunction in obesity is therefore related to overall adiposity rather than adipocyte hypertrophy.

Entities:  

Mesh:

Year:  2013        PMID: 24276464      PMCID: PMC3913808          DOI: 10.1210/jc.2013-3042

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway.

Authors:  C Farnier; S Krief; M Blache; F Diot-Dupuy; G Mory; P Ferre; R Bazin
Journal:  Int J Obes Relat Metab Disord       Date:  2003-10

2.  A quick, reliable, and automated method for fat cell sizing.

Authors:  Yourka D Tchoukalova; Deborah A Harteneck; R A Karwoski; J Tarara; Michael D Jensen
Journal:  J Lipid Res       Date:  2003-06-01       Impact factor: 5.922

3.  Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone.

Authors:  Leanne Wilson-Fritch; Alison Burkart; Gregory Bell; Karen Mendelson; John Leszyk; Sarah Nicoloro; Michael Czech; Silvia Corvera
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 4.  Oxidative stress and inflammation interactions in human obesity.

Authors:  Isabel Bondia-Pons; Lisa Ryan; J Alfredo Martinez
Journal:  J Physiol Biochem       Date:  2012-02-17       Impact factor: 4.158

5.  Relationship between the tissue level of cyclic AMP and the fat cell size of human adipose tissue.

Authors:  P Arner; J Ostman
Journal:  J Lipid Res       Date:  1978-07       Impact factor: 5.922

6.  Role of FoxO1 in FFA-induced oxidative stress in adipocytes.

Authors:  Angela R Subauste; Charles F Burant
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-20       Impact factor: 4.310

7.  Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals.

Authors:  J M Elbers; S de Jong; T Teerlink; H Asscheman; J C Seidell; L J Gooren
Journal:  Metabolism       Date:  1999-11       Impact factor: 8.694

8.  No difference in glycosphingolipid metabolism and mitochondrial function in glucocorticoid-induced insulin resistance in healthy men.

Authors:  M Brands; D H van Raalte; M João Ferraz; H P Sauerwein; A J Verhoeven; J M F G Aerts; M Diamant; M J Serlie
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

Review 9.  Inflammation and impaired adipogenesis in hypertrophic obesity in man.

Authors:  Birgit Gustafson; Silvia Gogg; Shahram Hedjazifar; Lachmi Jenndahl; Ann Hammarstedt; Ulf Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-21       Impact factor: 4.310

10.  Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells.

Authors:  B Jacobsson; U Smith
Journal:  J Lipid Res       Date:  1972-09       Impact factor: 5.922

View more
  75 in total

1.  Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals.

Authors:  C Bañuls; S Rovira-Llopis; S Lopez-Domenech; N Diaz-Morales; A Blas-Garcia; S Veses; C Morillas; V M Victor; M Rocha; A Hernandez-Mijares
Journal:  Int J Obes (Lond)       Date:  2017-06-20       Impact factor: 5.095

2.  Severe Burn Injury Induces Thermogenically Functional Mitochondria in Murine White Adipose Tissue.

Authors:  Craig Porter; David N Herndon; Nisha Bhattarai; John O Ogunbileje; Bartosz Szczesny; Csaba Szabo; Tracy Toliver-Kinsky; Labros S Sidossis
Journal:  Shock       Date:  2015-09       Impact factor: 3.454

3.  Insights into an adipocyte whitening program.

Authors:  Bradford G Hill
Journal:  Adipocyte       Date:  2015-01-28       Impact factor: 4.534

4.  Gene expression profile of subcutaneous adipose tissue in BMI-discordant monozygotic twin pairs unravels molecular and clinical changes associated with sub-types of obesity.

Authors:  M Muniandy; S Heinonen; H Yki-Järvinen; A Hakkarainen; J Lundbom; N Lundbom; J Kaprio; A Rissanen; M Ollikainen; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2017-04-25       Impact factor: 5.095

5.  Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity.

Authors:  Doan T M Ngo; Aaron L Sverdlov; Shakun Karki; Donia Macartney-Coxson; Richard S Stubbs; Melissa G Farb; Brian Carmine; Donald T Hess; Wilson S Colucci; Noyan Gokce
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-21       Impact factor: 4.310

Review 6.  Age-dependent obesity and mitochondrial dysfunction.

Authors:  Qilong Oscar Yang Li; Ines Soro-Arnaiz; Julián Aragonés
Journal:  Adipocyte       Date:  2017-03-15       Impact factor: 4.534

7.  Mitochondria-related transcriptional signature is downregulated in adipocytes in obesity: a study of young healthy MZ twins.

Authors:  Sini Heinonen; Maheswary Muniandy; Jana Buzkova; Adil Mardinoglu; Amaia Rodríguez; Gema Frühbeck; Antti Hakkarainen; Jesper Lundbom; Nina Lundbom; Jaakko Kaprio; Aila Rissanen; Kirsi H Pietiläinen
Journal:  Diabetologia       Date:  2016-10-12       Impact factor: 10.122

8.  GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1.

Authors:  Fen Xu; Beisi Lin; Xiaobin Zheng; Zonglan Chen; Huanyi Cao; Haixia Xu; Hua Liang; Jianping Weng
Journal:  Diabetologia       Date:  2016-02-29       Impact factor: 10.122

9.  Contribution of lipase deficiency to mitochondrial dysfunction and insulin resistance in hMADS adipocytes.

Authors:  J W E Jocken; G H Goossens; H Popeijus; Y Essers; N Hoebers; E E Blaak
Journal:  Int J Obes (Lond)       Date:  2015-10-16       Impact factor: 5.095

10.  Adipose tissue mitochondrial capacity associates with long-term weight loss success.

Authors:  R Jokinen; R Rinnankoski-Tuikka; S Kaye; L Saarinen; S Heinonen; M Myöhänen; E Rappou; S Jukarainen; A Rissanen; A Pessia; V Velagapudi; K A Virtanen; E Pirinen; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2017-12-05       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.